Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma

Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma : a Retrospective Study

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07363863

Enrollment

100

Registered

2026-01-23

Start date

2026-03-01

Completion date

2026-10-01

Last updated

2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Carcinoma

Brief summary

the study will discuss different pattern of treatment and the outcomes of locally advanced rectal carcinoma as a retrospective study. The study will be conducted at Department of Clinical Oncology, Sohag University Hospital and Sohag Cancer center, Sohag, Egypt. including patients diagnosed and treated between 2018 and 2025. and the data will be collected from reports .

Interventions

OTHERNo Intervention (subjects were previously treated with Onglyza®)

no intervention

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* patients who were more than18 years old at time of diagnosis. * Patients with histologically confirmed rectal carcinoma. * Stage II-III (locally advanced) disease at initial diagnosis.

Exclusion criteria

* Patients with distant metastasis at presentation. * Patients diagnosed with double malignancy. * Patients with incomplete medical records. * Organ failure

Design outcomes

Primary

Measure	Time frame
Estimation of overall survival (OS ).	2018 _ 2025
Estimation of Response rate .	2018-2025
Estimation of disease-free survival (DFS) .	2018-2025

Secondary

Measure	Time frame
treatment-related toxicity: (graded by CTCAE v5).	2018-2025

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026